To submit an abstract click on the SUBMIT ABSTRACT button at the bottom of the page and follow the step-by-step directions, which will enable you to provide the presenting author contact information, answer a few questions, and then upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in MICROSOFT WORD format.

Multiple submissions from the same data set will jeopardize abstract acceptance. The Organizing Committee urges submission of a single abstract from the entire group involved in the study.

Each applicant may submit a MAXIMUM of two (2) abstracts. If more than two (2) abstracts are submitted, only the last 2 submissions will be evaluated.

The deadline for abstract submission is April 8, 2005.

For each accepted abstract, one registration slot will be awarded to the presenting author. Co-authors of abstracts must complete an application to be considered for admittance into the Workshop.

Notifications of acceptance and format of presentation (oral or poster presentation) will be sent out on May 5, 2005. Guidelines for preparing your poster presentations will be sent if your abstract is accepted.

Upon notification of acceptance of abstract, the presenting author must REGISTER for the Workshop by May 17, 2005. Failure to register on or before the deadline may result in the loss of your acceptance in the Workshop.

Abstract presenters MAY NOT be changed after acceptance, without consent of the Organizing Committee.

SAMPLE ABSTRACT
To view a sample abstract, click here. The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.

ABSTRACT GUIDELINES

Format

The publisher of the abstract book does not allow figures or tables to appear in the submitted abstract.

The body of the uploaded abstract submission should not exceed 350 words; this limit excludes the title, authors and affiliations.

• Results and conclusions must be included; it is not acceptable to state that results will be presented.
• Abstract text may be divided into the following sections: objectives/aim, methods, results, conclusion(s)/discussion.
• Tables, graphs and references must NOT be used.
  
• Acknowledgements may be listed after the abstract.
• Generic (not trade) names for drugs should be used and written in full (not denoted by initials).
• Dosing regimens should be written in full. For example, TID should be written as three times daily.

Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title (not included in 350 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Authors/Affiliations (not included in 350 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. AN Author¹, AN Author² and AN Author³).

All author affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France.

Background
State the problem under investigation or a hypothesis. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Methods
Explain the experimental methods used. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

ADDITIONAL ABSTRACT INFORMATION

In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form:

Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

Resistance to New Antiretroviral Agents
Mechanisms of HIV Drug Resistance
HIV Pathogenesis, Fitness and Resistance
Clinical Implications of Resistance
Epidemiology
New Resistance Technologies and Interpretations

Abstract Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

ABSTRACT EVALUATION AND SCORING
The Organizing Committee (OC) and 4-6 members of the Scientific Committee (SC) will review each abstract. The OC evaluates all submitted abstracts. Members of the SC are selected for abstract categories based upon their individual expertise.
OC and SC members are instructed to review the abstracts for the quality and originality of the work and to score them numerically. All reviewers are instructed to abstain from scoring any abstract on which they are an author/co-author, have a financial or personal conflict of interest, or do not have the appropriate expertise to evaluate.
Scores for each abstract are averaged and the standard deviation is calculated to assess variability. If variability is high, outlier scores are identified and censored.
Abstracts with high variability in scores are discussed individually.

PUBLISHED ABSTRACT BOOK
Accepted abstracts will be standardized in font and presentation. Any scientific error that appears in the submitted abstract will appear in the printed abstract.

Subject to availability, copies of the Abstract Book will be available for sale after the Conference.